Suppr超能文献

琥珀酰化蛋白质组。

The succinated proteome.

机构信息

Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington.

出版信息

Mass Spectrom Rev. 2014 Mar-Apr;33(2):98-109. doi: 10.1002/mas.21382. Epub 2013 Sep 30.

Abstract

The post-translational modifications (PTMs) of cysteine residues include oxidation, S-glutathionylation, S-nitrosylation, and succination, all of which modify protein function or turnover in response to a changing intracellular redox environment. Succination is a chemical modification of cysteine in proteins by the Krebs cycle intermediate, fumarate, yielding S-(2-succino)cysteine (2SC). Intracellular fumarate concentration and succination of proteins are increased by hyperpolarization of the inner mitochondrial membrane, in concert with mitochondrial, endoplasmic reticulum (ER) and oxidative stress in 3T3 adipocytes grown in high glucose medium and in adipose tissue in obesity and diabetes in mice. Increased succination of proteins is also detected in the kidney of a fumarase deficient conditional knock-out mouse which develops renal cysts. A wide range of proteins are subject to succination, including enzymes, adipokines, cytoskeletal proteins, and ER chaperones with functional cysteine residues. There is also some overlap between succinated and glutathionylated proteins, suggesting that the same low pKa thiols are targeted by both. Succination of adipocyte proteins in diabetes increases as a result of nutrient excess derived mitochondrial stress and this is inhibited by uncouplers, which discharge the mitochondrial membrane potential (ΔΨm) and relieve the electron transport chain. 2SC therefore serves as a biomarker of mitochondrial stress or dysfunction in chronic diseases, such as obesity, diabetes, and cancer, and recent studies suggest that succination is a mechanistic link between mitochondrial dysfunction, oxidative and ER stress, and cellular progression toward apoptosis. In this article, we review the history of the succinated proteome and the challenges associated with measuring this non-enzymatic PTM of proteins by proteomics approaches.

摘要

半胱氨酸残基的翻译后修饰(PTMs)包括氧化、S-谷胱甘肽化、S-亚硝化和琥珀酰化,所有这些修饰都可以根据细胞内氧化还原环境的变化来改变蛋白质的功能或周转率。琥珀酰化是一种蛋白质中半胱氨酸的化学修饰,由三羧酸循环中间体富马酸盐修饰,生成 S-(2-琥珀酰)半胱氨酸(2SC)。在高葡萄糖培养基中培养的 3T3 脂肪细胞和肥胖和糖尿病小鼠的脂肪组织中,通过线粒体内膜去极化,与线粒体、内质网(ER)和氧化应激协同作用,细胞内富马酸盐浓度和蛋白质的琥珀酰化增加。在缺乏琥珀酸酶的条件性敲除小鼠的肾脏中也检测到蛋白质琥珀酰化增加,这种小鼠会发展出肾囊肿。广泛的蛋白质受到琥珀酰化的影响,包括酶、脂肪因子、细胞骨架蛋白和具有功能性半胱氨酸残基的 ER 伴侣蛋白。琥珀酰化蛋白和谷胱甘肽化蛋白之间也有一些重叠,这表明这两种修饰都靶向相同的低 pKa 巯基。糖尿病中脂肪细胞蛋白的琥珀酰化随着源自线粒体应激的营养过剩而增加,而解偶联剂可以抑制这种增加,解偶联剂会排出线粒体膜电位(ΔΨm)并缓解电子传递链。因此,2SC 可作为慢性疾病(如肥胖症、糖尿病和癌症)中线粒体应激或功能障碍的生物标志物,最近的研究表明,琥珀酰化是线粒体功能障碍、氧化和 ER 应激以及细胞向凋亡进展之间的机制联系。在本文中,我们回顾了琥珀酰化蛋白质组的历史以及通过蛋白质组学方法测量这种非酶促蛋白质翻译后修饰所面临的挑战。

相似文献

1
The succinated proteome.琥珀酰化蛋白质组。
Mass Spectrom Rev. 2014 Mar-Apr;33(2):98-109. doi: 10.1002/mas.21382. Epub 2013 Sep 30.
2
Succination of proteins in diabetes.糖尿病中的蛋白质琥珀酰化。
Free Radic Res. 2011 Jan;45(1):101-9. doi: 10.3109/10715762.2010.524643. Epub 2010 Oct 22.

引用本文的文献

7
Post-translational modifications and their implications in cancer.翻译后修饰及其在癌症中的意义。
Front Oncol. 2023 Sep 19;13:1240115. doi: 10.3389/fonc.2023.1240115. eCollection 2023.
8
Mitochondrial heterogeneity in diseases.疾病中的线粒体异质性。
Signal Transduct Target Ther. 2023 Aug 23;8(1):311. doi: 10.1038/s41392-023-01546-w.

本文引用的文献

5
The emerging role of fumarate as an oncometabolite.富马酸盐作为一种致癌代谢物的新兴作用。
Front Oncol. 2012 Jul 31;2:85. doi: 10.3389/fonc.2012.00085. eCollection 2012.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验